Zenpep DR 40,000 unit capsule 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FA2P5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,730
Award facts
- Contract value 100% obligated
- $31,730.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $31,730.41 to AmerisourceBergen Drug Corp for 100 units of Zenpep DR 40,000 unit capsules on January 15, 2026, with an ultimate completion date of January 16, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company being Cencora, Inc. (doing business as AmerisourceBergen). Zenpep is a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency, commonly prescribed for patients with cystic fibrosis and other pancreatic disorders.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. AmerisourceBergen's federal contract portfolio demonstrates its established capability to competitively fulfill DLA medical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FA2P5?
SPE2DR26FA2P5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FA2P5 worth?
The government has obligated $31,730 on SPE2DR26FA2P5.
Is contract SPE2DR26FA2P5 an order under another contract?
Yes. SPE2DR26FA2P5 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA2P5 competed?
The extent of competition for SPE2DR26FA2P5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award